Cullinan Therapeutics, Inc. CGEM Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s short-term investments?
- Cullinan Therapeutics, Inc. (CGEM) reported short-term investments of $276.8M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s short-term investments changed year-over-year?
- Cullinan Therapeutics, Inc.'s short-term investments increased by 21.8% year-over-year, from $227.17M to $276.8M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s short-term investments has grown at a 47.1% compound annual growth rate (CAGR), from $42.01M to $289.56M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.